Healthcare antitrust practitioners are grappling with the increased value and prominence of patient data in competition. In many respects, this data can be examined using traditional antitrust concepts. However, antitrust authorities and other stakeholders have also raised questions about consumers’ interests in mergers, or other competition practices from a privacy perspective. Privacy advocates have identified a range of possible welfare effects stemming from the commercial collection and us
...THIS ARTICLE IS NOT AVAILABLE FOR IP ADDRESS 3.133.12.172
Please verify email or join us to access premium content!